Abstract:BACKGROUND:Randomized controlled trials are considered the gold standard for evaluating experimental treatments but often require large sample sizes. Single-arm trials require smaller sample sizes but are subject to bias when using historical control data for comparative inferences. This article presents a Bayesian adaptive synthetic-control design that exploits historical control data to create a hybrid of a single-arm trial and a randomized controlled trial.METHODS:The Bayesian adaptive synthetic control design has two stages. In stage 1, a prespecified number of patients are enrolled in a single arm given the experimental treatment. Based on the stage 1 data, applying propensity score matching and Bayesian posterior prediction methods, the usefulness of the historical control data for identifying a pseudo sample of matched synthetic-control patients for making comparative inferences is evaluated. If a sufficient number of synthetic controls can be identified, the single-arm trial is continued. If not, the trial is switched to a randomized controlled trial. The performance of The Bayesian adaptive synthetic control design is evaluated by computer simulation.RESULTS:The Bayesian adaptive synthetic control design achieves power and unbiasedness similar to a randomized controlled trial but on average requires a much smaller sample size, provided that the historical control data patients are sufficiently comparable to the trial patients so that a good number of matched controls can be identified in the historical control data. Compared to a single-arm trial, The Bayesian adaptive synthetic control design yields much higher power and much smaller bias.CONCLUSION:The Bayesian adaptive synthetic-control design provides a useful tool for exploiting historical control data to improve the efficiency of single-arm phase II clinical trials, while addressing the problem of bias when comparing trial results to historical control data. The proposed design achieves power similar to a randomized controlled trial but may require a substantially smaller sample size.

Leveraging historical data to optimize the number of covariates and their explained variance in the analysis of randomized clinical trials.

Automated, efficient and model-free inference for randomized clinical trials via data-driven covariate adjustment

Including historical data in the analysis of clinical trials: Is it worth the effort?

The Use of Covariate Adjustment in Randomized Controlled Trials: An Overview

Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach

The covariate-adjusted residual estimator and its use in both randomized trials and observational settings

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

A Weighted Prognostic Covariate Adjustment Method for Efficient and Powerful Treatment Effect Inferences in Randomized Controlled Trials

Prognostic Covariate Adjustment for Binary Outcomes Using Stratification

Leveraging covariate adjustments at scale in online A/B testing

Adaptive selection of the optimal strategy to improve precision and power in randomized trials

An Empirical Likelihood Approach to Nonparametric Covariate Adjustment in Randomized Clinical Trials

Leveraging baseline covariates to analyze small cluster-randomized trials with a rare binary outcome

The optimal pre-post allocation for randomized clinical trials

Covariate adjustment in Bayesian adaptive randomized controlled trials

Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements

Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials

Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint

Precise unbiased estimation in randomized experiments using auxiliary observational data

Design and analysis of factorial clinical trials: The impact of one treatment's effectiveness on the statistical power and required sample size of the other

Model-Robust Inference for Clinical Trials that Improve Precision by Stratified Randomization and Covariate Adjustment